INTRODUCTION
Improvements in imaging modalities have made the detection of small, localized, renal masses considerably easier. There is, therefore, a corresponding rise in treatment, with radical nephrectomy (RN), partial nephrectomy (PN), thermal ablation or active surveillance among the treatments recommended by the American Urological Association (1) .
Recent studies have suggested that PN showed an equivalent oncological outcome for renal masses ,4 cm in size, and better postoperative preservation of overall renal function than RN to reduce the prevalence of chronic kidney disease (CKD) (2) . Patients with CKD [defined as an estimated glomerular filtration rate (eGFR) , 60 ml/min/1.73 m 2 ] often develop and progress to kidney failure, complications from decreased renal function, cardiovascular disease or death (3, 4) .
As more incidental, small renal masses are increasingly detected, and the negative relationship between long-term CKD and morbidity/mortality is uncovered, the preservation of kidney function and its related aggravating factors will continue to be emphasized, because conservative serum creatinine levels do not exactly reflect renal function and its degree of impairment (5, 6) . According to Coresh's study, 25% of patients with normal serum creatinine levels in the study had CKD (7) . Therefore, it is important to determine the parameters of renal function and aggravating factors of CKD after renal treatment. In this multicenter, retrospective study, we estimated the incidence of baseline CKD and postoperative development of CKD in patients with a single, small renal mass 4 cm of renal cell carcinoma (RCC), and assessed the parameters of renal function before and after either PN or RN.
PATIENTS AND METHODS
Approval of the study was obtained from the Institutional Review Board (IRB No. B-1202/145-102). A total of 1982 patients with sporadic RCC ,4 cm and non-metastatic RCC (pathologic T1aN0M0, International Union Against Cancer/ American Joint Committee on Cancer, 2009) at the time of surgery were collected from five institutions between January 2001 and December 2011 in the Republic of Korea. After excluding patients with a solitary kidney, metastatic disease, bilateral disease or previous renal surgery, 1928 patients were enrolled in the study. The patients' clinicopathological information was retrospectively reviewed. All patients had undergone PN or RN with a curative intent and had a follow-up of at least 6 months. Follow-up consisted of a history, physical examination, routine blood work and serum chemistry, chest radiography and abdomen computed tomography (CT) every 6 months for 3 years, and then yearly in most patients. Other radiographic evaluations, including bone scan, MRI or positron emission tomography -CT, were performed when clinically indicated.
Patients were divided into CKD and non-CKD groups before ( pre-CKD vs. pre-non-CKD) and after surgery (post-CKD vs. post-non-CKD), according to their renal function calculated by the Modification of Diet in Renal Disease (MDRD) equation (8 To evaluate renal function and CKD, serum creatinine levels were measured preoperatively and at the 6-month follow-up postoperatively in all patients using the Jaffé method. The four-variable MDRD formula (eGFR ¼ 186.3 Â Pcr 21.154 Â age 20.203 Â 0.742; if female) using serum creatinine levels and demographic variables was used to estimate the glomerular filtration rate (GFR). The outcome measure used in this study was the development of new onset CKD with an estimated GFR of ,60 ml/min/1.73 m 2 after surgery, with an interval of at least 6 months after the operation. All patients with pre-CKD (n ¼ 192) and those with a deficiency of postoperative serum creatinine level (n ¼ 60) were excluded from the study when evaluating the incidence rate of developing post-CKD and post-CKD risk factors (RFs), yielding a total of 1676 patients.
Comparisons of the qualitative and quantitative variables of the CKD and non-CKD groups before and after PN or RN were performed using a x 2 test or independent t test as appropriate. After prequalification of demographics and clinicopathological parameters with univariate analysis, significant factors were evaluated using logistic regression analysis to determine the association of the independent variables with baseline pre-CKD and development of post-CKD. Null hypotheses of no difference were rejected if P values were ,0.05 (two-tailed). All data analyses were processed with SPSS 18.0 statistical software (SPSS, Inc., Chicago, IL, USA).
RESULTS
Among the 1928 patients with a single small renal mass 4 cm, pre-CKD was found in 10.0% of patients, whereas 1244 Chronic kidney disease in RCC 16.1% of patients developed post-CKD (Tables 1 and 2 Table 2 ). PN was performed more frequently than RN (PN 72.0% vs. RN 28.0%), especially in post-non-CKD groups, and RN (78.4%) was performed more often in the post-CKD groups (PN 21.6%). In the post-non-CKD (n ¼ 1407, 83.9%) and post-CKD groups (n ¼ 269, 16.1%), statistically different RFs for post-CKD were male gender, BMI, diagnostic age, diabetes, hypertension, ECOG, tumor size, preoperative albumin level, operating time, surgical type (PN or RN) and transfusion in univariate analysis (P , 0.05, Table 2 ).
After multivariate analyses, significantly different RFs for CKD before and after surgery were male gender (OR 3.55 vs. OR 3.78, P , 0.001, respectively), and diagnostic age (OR 1.04, P ¼ 0.002 vs. OR 1.05, P , 0.001). In addition, hypertension (OR 0.46, P ¼ 0.006), serum albumin (OR 0.23, P , 0.001) and calcium (OR 2.06, P ¼ 0.015) were significant RFs for pre-CKD, and preoperative serum creatinine levels (OR 1.90, P ¼ 0.023), and surgical type (either RP or PN) were RFs for post-CKD (OR 11.89, P , 0.001) ( Tables 3 and 4) .
DISCUSSION
This retrospective multicenter study deals with the prevalence of both pre-CKD and newly developed post-CKD cases and with the RFs for patients with a single renal tumor 4 cm (clinical T1a) before and after PN or RN as a curative treatment at five Korean tertiary hospitals. It is the first study to report the incidence rate of CKD before and after nephrectomy in Korea.
During 10-year follow-ups (at least a minimum 6-month follow-up) on 1928 patients enrolled in this study, 10.0% had untreated pre-CKD. This prevalence of pre-CKD among patients with a renal tumor is lower than that of other reports, showing that 22 -30% of patients presenting for surgery had baseline pre-CKD (7,9 -11) . This discrepancy in the prevalence of pre-CKD may be explained by the baseline demographics of enrolled patients. Most enrolled patients in this study were young, with a mean age of 55.0 (+12.4) years, and had a low BMI (median 24.7 cm/m 2 ) with a good performance status (,ECOG 3 [80.8%]). This rationale presumes that there is a lesser risk of severe metabolic disease and cardiovascular disease negatively affecting renal function that would result in a lower prevalence of pre-CKD (Table 1) . However, similar to our results, many other reports also indicate a low pre-CKD prevalence (10.0 -16.1%) among the general population (7,12 -15) . In addition, for patients .65 years of age, this study showed a 19.5% prevalence of pre-CKD, which is higher than the overall prevalence rate; thus, more attention should be paid to renal function in older people presenting with a renal mass for surgery.
To evaluate the characteristics of pre-CKD and to define any predisposing RFs, male gender, age at diagnosis, hypertension and serum albumin and calcium levels were shown to be significant, independent RFs (P , 0.01) and major influential parameters on renal function between pre-CKD and pre-non-CKD groups before surgery in this study (Table 3 ). An older age at diagnosis of a renal mass (OR 1.04), male gender (OR 3.55), hypertension (OR 0.46) and serum calcium levels (OR 2.06) and lower serum albumin levels (OR 0.23) significantly increased the prevalence of pre-CKD. These pre-CKD RFs, including increasing age, have already been identified as being associated with renal function (4, 5, 13, 16, 17) . The higher prevalence of CKD and mortality in males have been reported in many animal and clinical studies, and are attributed to many biological and social factors, such as sex hormones (18 -20) , social activities, including drinking alcohol and smoking, occupational stress and lack of physical activity (21, 22) . Hypertension is also a wellknown predisposing factor for the development of CKD because of the increasing risk of damage to the cardiovasculature, which results in impaired renal function (7, 9, 10, 13, 15) . Other RFs for pre-CKD are serum albumin and calcium levels, which are known as functional renal markers, as well 
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Chronic kidney disease in RCC as markers of end-stage renal disease, renal tubular acidosis, diabetes and other diseases (16, 17, 23) . Therefore, clinicians should be aware of pre-CKD in patients with these RFs if they plan to undergo treatment for a small renal mass (cT1a) and should focus on the patient's preoperative renal function and demographical parameters to evaluate the risk for post-CKD. Among 1676 non-CKD patients before surgery, 16.1% of the patients developed post-CKD (28.3% for .65-year-old patients) with significant RFs, including male gender (OR 3.78), age at diagnosis (OR 1.05), preoperative serum creatinine levels (OR 1.90) and surgical type (OR 11.89, P , 0.05, Table 4 ). The incidence of post-CKD is also relatively low compared with 30 -50% for other reported events due to the aforementioned differences in baseline demographics of enrolled patients (2, 4, 11, 16) .
Among the significant RFs for post-CKD, the strongest RF is surgical type of RN, which influences kidney function with an odds ratio (OR) of 11.8 ( Table 4 ), suggesting that PN should be recommended first to prevent post-CKD after considering the factors and thorough discussions with patients and responsible caregivers. However, two recent papers suggested that PN showed a significant benefit for CKD patients but was unlikely to prevent surgical CKD compared with RN after considering its oncologic control and morbidity (11, 24, 25) . These authors also admitted that in the past, insufficient numbers of patients who underwent PN were enrolled to compare with patients who underwent RN. Patients with PN should be enrolled with further long-term follow-up because the surgical techniques and instruments for use in PN improved compared with the past. Another study from Lane et al. suggested that the benefits of PN were lower risks of progression and mortality compared with medically induced CKD (11) .
The generally accepted post-CKD RFs after nephrectomy, such as diabetes, hypertension and operating time including ischemic time for PN, have not been statistically proven to affect the development of CKD (P . 0.05) (3 -5,7) . In particular, operative time including the ischemic time is not a significant RF for CKD because renal masses 4 cm are not large enough to affect postoperative changes in renal function and minimal parenchymal and vascular injury during PN. Less than 30 min of ischemic time is required to avoid renal ischemic injury in PN; operating time in this study was tolerably short, with a median time of 160 min, including a median ischemic time of 23 min (total mean operating time 170.1 + 62.2 min; total mean ischemic time 25.1 + 14.0 min; data not shown). Additionally, the resected renal parenchyma of the renal tumor is too small to affect postoperative renal function, so renal function is preserved after PN to a large extent.
Another parameter that negatively affects renal function is chronic renovascular disease, such as diabetes and hypertension, and they are not found to be significant RFs for incident post-CKD after either PN or RN. This observation is likely because the patients are young with good performance status (ECOG 1 or 2, 97.2%), and few patients have had hypertension or diabetes .5 years that would negatively affect renal function after surgery. Another explanation is that the surgical type of RN has a major influential effect, with an OR of 11.89, such that pre-existing, chronic diseases do not affect the early development of post-CKD. However, one would expect that hypertension and diabetes would become influential RFs for CKD over time.
Our study has some limitations. First, despite this being the first meaningful report of the Korean baseline incidence of CKD, further randomized prospective studies with a larger sample size, including a non-surgical control group, is needed to evaluate RFs for CKD. Second, the CKD equation, MDRD and serum creatinine levels are not very accurate tools for defining actual kidney function. More accurate tools are needed to evaluate renal function, such as 24 h creatinine clearance, serum cystatin-C or the CKD epidemiology equation (CKD-EPI) (6, 26, 27) . Third, the RFs in this study were observed at two specific time points, so that the laboratory results might be influenced by other factors such as medications and nutritional states. More data from different time points are needed to evaluate the actual influence of the RFs we suggested. Finally, this study did not deal with sequelae or metabolically associated post-CKD (28) (29) (30) .
CONCLUSIONS
This study shows that patients with a small renal mass and a normal contralateral kidney should be carefully evaluated in terms of preoperative renal function to prevent post-CKD, especially if they are males with a history of hypertension. In addition, PN should be first considered rather than RN to reduce the risk of post-CKD.
